Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Zoetis Inc (NYSE:ZTS)

46.40
Delayed Data
As of May 23
 -0.66 / -1.40%
Today’s Change
37.73
Today|||52-Week Range
55.38
-3.17%
Year-to-Date
Bill Ackman Slashes Position in Zoetis
May 20 / GuruFocus News - Paid Partner Content
George Soros bet big on gold
May 17 / CNNMoney.com
Cramer's 'Off the Charts': Pet-Care Stocks Are Investors' Best Friends
May 17 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close47.06
Today’s open47.00
Day’s range46.40 - 47.04
Volume2,356,010
Average volume (3 months)4,495,407
Market cap$23.4B
Dividend yield0.82%
Data as of 4:02pm ET, 05/23/2016

Growth & Valuation

Earnings growth (last year)-41.38%
Earnings growth (this year)+4.92%
Earnings growth (next 5 years)+13.15%
Revenue growth (last year)-0.42%
P/E ratio61.5
Price/Sales5.05
Price/Book21.92

Competitors

 Today’s
change
Today’s
% change
MYLMylan NV-0.30-0.72%
VRTXVertex Pharmaceutica...-0.28-0.33%
ALXNAlexion Pharmaceutic...-0.01-0.01%
INCYIncyte Corp+3.03+3.90%
Data as of 4:00pm ET, 05/23/2016

Financials

Next reporting dateAugust 2, 2016
EPS forecast (this quarter)$0.44
Annual revenue (last year)$4.8B
Annual profit (last year)$339.0M
Net profit margin7.11%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Juan Ramón Alaix
Executive Vice President &
President-US Operations
Kristin C. Peck
Corporate headquarters
Florham Park, New Jersey

Forecasts

Partner Offers

Search for Jobs